Clinical trial
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly…
NCT00107471 · Children's Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00107471 |
|---|---|
| Title | Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma |
| Official title | A Phase I/II Study of Topotecan With G-CSF and Radiation Therapy in Children With Malignant Intrinsic Pontine Brainstem Gliomas of Childhood |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain Tumors, Central Nervous System Tumors |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, topotecan hydrochloride, radiation therapy |
| Enrollment | 7 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2007 |
| First posted | Apr 6, 2005 |
| Last update posted | Dec 10, 2013 |
| Countries | Australia, Canada, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: